Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Glassock

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Nephrology|July 26, 2014
Incidence and relevance of proteinuria in bevacizumab-treated patients: pooled analysis from randomized controlled trialsRichard A Lafayette, Bruce McCall, Nicole Li, et al.
Optics Letters|July 2, 2016
High peak and average power Ti:sapphire thin disk amplifier with extraction during pumpingVladimir Chvykov, Huabao Cao, Roland Nagymihaly, et al.
Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.
Nephrology News & Issues|April 16, 2013
A quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removalTom F Parker, Raymond Hakim, Allen R Nissenson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 27, 2014
Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providersDaniel E Weiner, Steven M Brunelli, Abigail Hunt, et al.
Kidney International Reports|September 22, 2025
Efficacy of Acthar gel and Tacrolimus in DNA-JB9 Positive Fibrillary GlomerulopathyJames A Tumlin, Amber Podoll, Nelson Kopyt, et al.
Seminars in Dialysis|September 27, 2013
Dialysis initiation: what's the rush?Steven J Rosansky, Giovanni Cancarini, William F Clark, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.
JAMA|August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Hong Zhang, Muh Geot Wong, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Nephrology|July 26, 2014
Incidence and relevance of proteinuria in bevacizumab-treated patients: pooled analysis from randomized controlled trialsRichard A Lafayette, Bruce McCall, Nicole Li, et al.
Optics Letters|July 2, 2016
High peak and average power Ti:sapphire thin disk amplifier with extraction during pumpingVladimir Chvykov, Huabao Cao, Roland Nagymihaly, et al.
Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.
Nephrology News & Issues|April 16, 2013
A quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removalTom F Parker, Raymond Hakim, Allen R Nissenson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 27, 2014
Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providersDaniel E Weiner, Steven M Brunelli, Abigail Hunt, et al.
Kidney International Reports|September 22, 2025
Efficacy of Acthar gel and Tacrolimus in DNA-JB9 Positive Fibrillary GlomerulopathyJames A Tumlin, Amber Podoll, Nelson Kopyt, et al.
Seminars in Dialysis|September 27, 2013
Dialysis initiation: what's the rush?Steven J Rosansky, Giovanni Cancarini, William F Clark, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.
JAMA|August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Hong Zhang, Muh Geot Wong, et al.
Pageof 3